Trump’s abandoned promise to bring down drug prices, explained image

Vox, February 2, 2018
Dylan Scott, quoting Rachel Sachs (Academic Fellow Alumna)


Read the Full Article

From the article:

One year into Donald Trump’s presidency, as he delivered his first State of the Union address, he has more or less abandoned his outspoken pledges to bring down the cost of America’s medicines, the highest in the world.

“Despite continuing rhetoric that the pharmaceutical companies are getting away with murder,” said Rachel Sachs, a Washington University in St. Louis professor who follows drug pricing, “he has done absolutely nothing on this issue, and that has actually surprised me.”

But the point is: Nobody, especially President Trump, is really talking about prices anymore.

“Patient out-of-pocket costs are certainly a problem that needs to be addressed,” Sachs said, “but it can’t be the solution to drug pricing.”

Read more here!

health care finance health care reform health law policy pharmaceuticals public health rachel sachs regulation